Max Healthcare Institute · NSE: MAXHEALTH · BSE: 543220
Q4 FY23 results · Jan–Mar 2023
Max Healthcare Institute reported revenue from operations of ₹1,214.51 crore (up 29.4% from Q4 FY22) and net profit of ₹250.92 crore (up 102.8% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,214.51 | 938.80 | +29.4% | 1,141.24 | +6.4% |
| Other income | 40.22 | 24.71 | +62.8% | 45.15 | −10.9% |
| Total income | 1,254.73 | 963.51 | +30.2% | 1,186.39 | +5.8% |
| Profit before tax | 300.68 | 154.39 | +94.8% | 281.44 | +6.8% |
| Net profit for the period | 250.92 | 123.73 | +102.8% | 222.41 | +12.8% |
| EPS, basic (₹) | 2.58 | 1.28 | +102.0% | 2.29 | +12.9% |
| Net margin (%) | 20.7 | 13.2 | 19.5 |
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 507.32 | 381.20 | +33.1% | 481.97 | +5.3% |
| Other income | 40.61 | 27.91 | +45.5% | 44.04 | −7.8% |
| Total income | 547.93 | 409.11 | +33.9% | 526.01 | +4.2% |
| Profit before tax | 150.96 | 82.54 | +82.9% | 157.05 | −3.9% |
| Net profit for the period | 126.37 | 66.15 | +91.0% | 122.14 | +3.5% |
| EPS, basic (₹) | 1.30 | 0.68 | +91.2% | 1.26 | +3.2% |
| Net margin (%) | 24.9 | 17.4 | 25.3 |
Consolidated
- Filed with BSE
- 17 May 2023, 17:44 IST
- Board meeting
- 16 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 17 May 2023, 17:44 IST
- Board meeting
- 16 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE